Burns are exceedingly challenging due to
the high risk of infection since the skin is no longer a
barrier to bacteria. As well, skin grafts offer potential
for a number of complications.
A graft "takes" or is successful when new blood
vessels and tissue form in the injured area. Sometimes, skin
grafts do not take because of early complications such as
infection, which is the most common cause of graft failure.
Based
upon preliminary results from a clinical study conducted
at the Guadalajara Civil Hospital, when patients are treated
with Microcyn® Technology in
a comprehensive treatment program, healing of the burns
is accelerated, the levels of pain and infection reduced and
the patient hospital stay, on average, is reduced from 28.6
days to 14.9 days with significant cost savings per patient.
In addition to these promising results, physicians are also
able to more easily treat facials burns since Microcyn® Technology
can be used freely about the face, eyes and mouth without
concern about toxicity.
Based
upon preliminary results from a clinical study conducted
at the Guadalajara Civil Hospital, when patients are treated
with